por
Florian Janisch,
Florian Janisch,
Christina Kienapfel,
Constantin Fühner,
Thomas Klotzbücher,
Phillip Marks,
Tobias Hillemacher,
Christian P. Meyer,
Takehiro Iwata,
Takehiro Iwata,
Mehdi Kardoust Parizi,
Mehdi Kardoust Parizi,
Guido Sauter,
Margit Fisch,
Shahrokh F. Shariat,
Shahrokh F. Shariat,
Shahrokh F. Shariat,
Shahrokh F. Shariat,
Shahrokh F. Shariat,
Shahrokh F. Shariat,
Roland Dahlem,
Michael Rink
Publicado 2021
“...; 0.001). The most common first-line TKIs were Sunitinib (65.6%), Sorafenib (19.
5%), and Pazopanib (10.3...
”
Enlace del recurso
article